Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder

Journal of Affective Disorders

Volumn 159, Issue , 2014, Pages 23-30

  Bortolasci, Chiara Cristina ^a   Vargas, Heber Odebrecht ^a   Souza Nogueira, André ^a   Barbosa, Décio Sabbatini ^b   Moreira, Estefania Gastaldello ^c   Nunes, Sandra Odebrecht Vargas ^a   Berk, Michael ^d,e   Dodd, Seetal ^d,e   Maes, Michael ^d,f  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Health Sciences Center   (Brazil)

^c Biological Sciences Center   (Brazil)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Bipolar disorder; Cytokines; Depression; Inflammation; Oxidative stress; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ARYLDIALKYLPHOSPHATASE; GENETIC MARKER;

ADULT; ARTICLE; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FALSE POSITIVE RESULT; FEMALE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; NITROSATIVE STRESS; PREDICTION; PRIORITY JOURNAL; SMOKING; TOBACCO DEPENDENCE; BLOOD; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; STATISTICAL MODEL;

ADULT; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING;

EID: 84895555847     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.02.018     Document Type: Article

References (61)

1. M. Aviram, M. Rosenblat, C.L. Bisgaier, R.S. Newton, S.L. Primo-Parmo, and B.N. La Du Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase J. Clin. Invest. 101 8 1998 1581 1590
2. A.O. Barim, S. Aydin, R. Colak, E. Dag, O. Deniz, and I. Sahin Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment Clin. Biochem. 42 10-11 2009 1076 1081
3. M. Berk, F. Kapczinski, A.C. Andreazza, O.M. Dean, F. Giorlando, M. Maes, M. Yucel, C.S. Gama, S. Dodd, B. Dean, P.V. Magalhaes, P. Amminger, P. McGorry, and G.S. Malhi Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors Neurosci. Biobehav. Rev. 35 3 2011 804 817
4. N. Breslau, S.P. Novak, and R.C. Kessler Daily smoking and the subsequent onset of psychiatric disorders Psychol Med. 34 2 2004 323 333 PubMed PMID: 14982138
5. N. Breslau, L.R. Schultz, E.O. Johnson, E.L. Peterson, and G.C. Davis Smoking and the risk of suicidal behavior: a prospective study of a community sample Arch Gen Psychiatry 62 3 2005 328 334 PubMed PMID: 15753246
6. J. Camps, I. Pujol, F. Ballester, J. Joven, and J.M. Simo Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria Antimicrob. Agents Chemother. 55 4 2011 1325 1331
7. C.C. Cheng, C.M. Hsueh, C.Y. Chen, T.H. Chen, and S.L. Hsu Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-?B-dependent pathway Biochem. Biophys. Res. Commun. 437 1 2013 55 61
8. L.G. Costa, G. Giordano, and C.E. Furlong Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on Biochem. Pharmacol. 81 3 2011 337 344
9. C.M. Del Ben, J.A.A. Vilela, J.A.S. Crippa, J.E.C. Hallak, C.M. Labate, and A.W. Zuardi Confiabilidade da Entrevista Clinica Estruturada para o D.S.M.- IV verso clinica traduzida para o portugues Rev. Bras. Psiquiatr. 23 3 2001 156 159
10. I. Edirisinghe, and I. Rahman Cigarette smoke-mediated oxidative stress, shear stress, and endothelial dysfunction: role of VEGFR2 Ann. N. Y. Acad. Sci. 1203 2010 66 72
11. A. Ezzaher, D.H. Mouhamed, A. Mechri, M. Araoud, F. Neffati, W. Douki, L. Gaha, and M.F. Najjar Lower paraoxonase 1 activity in Tunisian bipolar I patients Ann. Gen. Psychiatry 21 9 2010 36
12. A. Ezzaher, D.H. Mouhamed, A. Mechri, F. Neffati, J. Rejeb, A. Omezzine, W. Douki, A. Bouslama, L. Gaha, and M.F. Najjar Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene J. Affect. Disord. 139 1 2012 12 17
13. C.E. Furlong, S.M. Suzuki, R.C. Stevens, J. Marsillach, R.J. Richter, G.P. Jarvik, H. Checkoway, A. Samii, L.G. Costa, A. Griffith, J.W. Roberts, D. Yearout, and C.P. Zabetian Human PON1, a biomarker of risk of disease and exposure Chem. Biol. Interact. 187 1-3 2010 355 361
14. B. Goswami, D. Tayal, N. Gupta, and V. Mallika Paraoxonase: a multifaceted biomolecule Clin. Chim. Acta 410 1-2 2009 1 12
15. C. Gouedard, R. Barouki, and Y. Morel Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism Mol. Cell. Biol. 24 12 2004 5209-2022
16. D. Haj Mouhamed, A. Ezzaher, A. Mechri, F. Neffati, A. Omezzine, A. Bouslama, L. Gaha, W. Douki, and M.F. Najjar Effect of cigarette smoking on paraoxonaseÿ1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms Environ. Health Prev. Med 17 4 2012 316 321
17. B. Isik, R.S. Isik, A. Ceylan, and O. Calik Trace elements and oxidative stress in chronic obstructive pulmonary disease Saudi Med. J. 26 12 2005 1882 1885
18. M. Jamal, A.J. Willem Van der Does, P. Cuijpers, and B.W. Penninx Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder Drug Alcohol Depend 126 1-2 2012 138 146 10.1016/j.drugalcdep.2012.05.001 Epub 2012 May 26. PubMed PMID: 22633368
19. R.W. James, I. Leviev, and A. Righetti Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease Circulation 101 19 2000 2252 2257
20. J. Kodydková, L. Vávrová, M. Zeman, R. Jirák, J. Macásek, B. Stanková, E. Tvrzická, and A. Zák Antioxidative enzymes and increased oxidative stress in depressive women Clin Biochem. 42 13-14 2009 1368 1374 10.1016/j.clinbiochem.2009.06.006 Epub 2009 Jun 13. PubMed PMID: 19527700
21. E. Kotan, L. Alpsoy, M. Anar, A. Aslan, and G. Agar Protective role of methanol extract of Cetraria islandica (L.) against oxidative stress and genotoxic effects of AFB? in human lymphocytes in vitro Toxicol. Ind. Health 27 7 2011 599 605
22. V.O. Kotan, E. Sarandol, E. Kirhan, G. Ozkaya, and S. Kirli Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study Prog. Neuropsychopharmacol. Biol. Psychiatry 35 5 2011 1284 1290
23. K. Kotani, K. Tsuzaki, and N. Sakane Paraoxonase-1 gene Q192R polymorphism and reactive oxygen metabolites J. Int. Med. Res. 40 4 2012 1513 1518
24. Y. Kumon, T. Suehiro, Y. Ikeda, and K. Hashimoto Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6 Life Sci. 73 22 2003 2807 2815
25. D.A. Lawlor, I.N. Day, T.R. Gaunt, L.J. Hinks, N. Timpson, S. Ebrahim, and G. Davey Smith The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Womens Heart and Health Study J. Epidemiol. Community Health 61 1 2007 85 87
26. B. Leonard, and M. Maes Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression Neurosci. Biobehav. Rev. 36 2 2012 764 785
27. A. Leone Interactive effect of combined exposure to active and passive smoking on cardiovascular system Recent Pat. Cardiovasc. Drug Discov. 6 1 2011 61 69
28. D. Litvinov, H. Mahini, and M. Garelnabi Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases N. Am. J. Med. Sci. 4 11 2012 523 532
29. M.E. Liu, Y.C. Liao, R.T. Lin, Y.S. Wang, E. Hsi, H.F. Lin, K.C. Chen, and S.H. Juo A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis Atherosclerosis 228 1 2013 161 167
30. M. Mackness, and B. Mackness Targeting paraoxonase-1 in atherosclerosis Expert Opin. Ther. Targets 17 7 2013 829 837
31. M. Maes, N. De Vos, R. Pioli, P. Demedts, A. Wauters, H. Neels, and A. Christophe Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness J. Affect Disord. 58 3 2000 241 246 PubMed PMID: 10802134
32. M. Maes, S. Scharpé, H.Y. Meltzer, E. Bosmans, E. Suy, J. Calabrese, and P. Cosyns Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression Psychiatry Res. 49 1 1993 11 27 PubMed PMID: 7511248
33. M. Maes, H.Y. Meltzer, E. Bosmans, R. Bergmans, E. Vandoolaeghe, R. Ranjan, and R. Desnyder Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression J. Affect Disord. 34 4 1995 301 309 PubMed PMID: 8550956
34. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Prog. Neuropsychopharmacol. Biol. Psychiatry 35 3 2011 676 692
35. M. Maes, R. Smith, A. Christophe, E. Vandoolaeghe, A. Van Gastel, H. Neels, P. Demedts, A. Wauters, and H.Y. Meltzer Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers Acta Psychiatr. Scand. 95 3 1997 212 221
36. M. Maes, M. Kubera, and J.C. Leunis The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression Neuro. Endocrinol. Lett. 29 1 2008 117 124
37. M. Maes, M. Kubera, E. Obuchowiczwa, L. Goehler, and J. Brzeszcz Depressions multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways Neuro Endocrinol. Lett. 32 1 2011 7 24
38. M. Maes, P. Ruckoanich, Y.S. Chang, N. Mahanonda, and M. Berk Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients Prog. Neuropsychopharmacol. Biol. Psychiatry 35 3 2011 769 783
39. K.M. Malone, C. Waternaux, G.L. Haas, T.B. Cooper, S. Li, and J.J. Mann Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders Am. J. Psychiatry 160 4 2003 773 779 PubMed PMID: 12668368
40. J. Milara, and J. Cortijo Tobacco, inflammation, and respiratory tract cancer Curr. Pharm. Des. 18 26 2012 3901 3938
41. M.F. Minicucci, P.S. Azevedo, B.F. Polegato, S.A. Paiva, and L.A. Zornoff Cardiac remodeling induced by smoking: concepts, relevance, and potential mechanisms Inflamm. Allergy Drug Targets 11 6 2012 442 447
42. R.A. Moreno, and D.H. Moreno Hamilton and Montgomery & Asberg depression rating scales Rev. Psiquiatr. Clin. 25 1998 262 272
43. S. Moylan, M. Maes, N.R. Wray, and M. Berk The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications Mol. Psychiatry 18 5 2012 595 606
44. D.S. Ng, T. Chu, B. Esposito, P. Hui, P.W. Connelly, and P.L. Gross Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia Cardiovasc. Pathol. 17 4 2008 226 232
45. E. Nishio, and Y. Watanabe Cigarette smoke extract is a modulator of mitogenic action in vascular smooth muscle cells Life Sci. 62 15 1998 1339 1347
46. S.O. Nunes, H.O. Vargas, E. Prado, D.S. Barbosa, L.P. de Melo, S. Moylan, S. Dodd, and M. Berk The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence Neurosci. Biobehav. Rev. 37 8 2013 1336 1345
47. J.A. Pasco, L.J. Williams, F.N. Jacka, F. Ng, M.J. Henry, G.C. Nicholson, M.A. Kotowicz, and M. Berk Tobacco smoking as a risk factor for major depressive disorder: population-based study Br. J. Psychiatry 193 4 2008 322 326
48. A.A. Pezzulo, E.E. Hornick, M.V. Rector, M. Estin, A.C. Reisetter, P.J. Taft, S.C. Butcher, A.B. Carter, J.R. Manak, D.A. Stoltz, and J. Zabner Expression of human paraoxonase 1 decreases superoxide levels and alters bacterial colonization in the gut of Drosophila melanogaster PLoS One 7 8 2012 e43777
49. A.E. Razavi, M. Ani, M. Pourfarzam, and G.A. Naderi Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity J. Res. Med. Sci. 17 11 2012 1020 1026
50. N.E. Rice, S. Bandinelli, A.M. Corsi, L. Ferrucci, J.M. Guralnik, M.A. Miller, M. Kumari, A. Murray, T.M. Frayling, and D. Melzer The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies Int. J. Epidemiol. 38 5 2009 1374 1379
51. R.J. Richter, G.P. Jarvik, and C.E. Furlong Paraoxonase 1 status as a risk factor for disease or exposure Adv. Exp. Med. Biol. 660 2010 29 35
52. L. Rothem, C. Hartman, A. Dahan, J. Lachter, R. Eliakim, and R. Shamir Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum Free Radic. Biol. Med. 43 5 2007 730 739
53. W. Samy, and M.A. Hassanian Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin Arab. J. Gastroenterol 12 2 2011 80 85
54. A. Sarandol, E. Sarandol, S.S. Eker, E.U. Karaagac, B.Z. Hizli, M. Dirican, and S. Kirli Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 30 6 2006 1103 1108
55. D.M. Shih, L. Gu, Y.R. Xia, M. Navab, W.F. Li, S. Hama, L.W. Castellani, C.E. Furlong, L.G. Costa, A.M. Fogelman, and A.J. Lusis Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 394 6690 1998 284 287
56. S. Singh, V. Kumar, S. Thakur, B.D. Banerjee, R.S. Rautela, S.S. Grover, D.S. Rawat, S.T. Pasha, S.K. Jain, R.L. Ichhpujani, and A. Rai Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides Toxicol. Appl. Pharmacol. 252 2 2011 130 137
57. J.W. Stephens, S.C. Bain, and S.E. Humphries Gene-environment interaction and oxidative stress in cardiovascular disease Atherosclerosis 200 2 2008 229 238
58. P.F. Sullivan Spurious genetic associations Biol. Psychiatry 61 10 2007 1121 1126
59. J.F. Teiber, and D.I. Draganov High-performance liquid chromatography analysis of N-acyl homoserine lactone hydrolysis by paraoxonases Methods Mol Biol. 692 2011 291 298 10.1007/978-1-60761-971-0-21 PubMed PMID: 21031320
60. E. Thomas-Moya, M. Gianotti, A.M. Proenza, and I. Llado Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved Mol. Med. 13 3-4 2007 203 209
61. H.O. Vargas, S.O. Nunes, M.R. de Castro, M.M. Vargas, D.S. Barbosa, C.C. Bortolasci, K. Venugopal, S. Dodd, and M. Berk Oxidative stress and inflammatory markers are associated with depression and nicotine dependence Neurosci. Lett. 544 2013 136 140 10.1016/j.neulet.2013.03.059 Epub 2013 Apr 11. PubMed PMID: 23583694